176 related articles for article (PubMed ID: 28409566)
21. Determinants of Propranolol's Selective Effect on Loss Aversion.
Sokol-Hessner P; Lackovic SF; Tobe RH; Camerer CF; Leventhal BL; Phelps EA
Psychol Sci; 2015 Jul; 26(7):1123-30. PubMed ID: 26063441
[TBL] [Abstract][Full Text] [Related]
22. Noradrenergic stimulation increases fear memory expression.
Kausche FM; Zerbes G; Kampermann L; Müller JC; Wiedemann K; Büchel C; Schwabe L
Eur Neuropsychopharmacol; 2021 Feb; 43():71-81. PubMed ID: 33358539
[TBL] [Abstract][Full Text] [Related]
23. Opposite effects of noradrenergic and glucocorticoid activation on accuracy of an episodic-like memory.
Roozendaal B; Mirone G
Psychoneuroendocrinology; 2020 Apr; 114():104588. PubMed ID: 32085987
[TBL] [Abstract][Full Text] [Related]
24. The impact of Yohimbine-induced arousal on facets of behavioural impulsivity.
Herman AM; Critchley HD; Duka T
Psychopharmacology (Berl); 2019 Jun; 236(6):1783-1795. PubMed ID: 30635680
[TBL] [Abstract][Full Text] [Related]
25. Dopamine-Dependent Loss Aversion during Effort-Based Decision-Making.
Chen X; Voets S; Jenkinson N; Galea JM
J Neurosci; 2020 Jan; 40(3):661-670. PubMed ID: 31727795
[TBL] [Abstract][Full Text] [Related]
26. Representational similarity analysis offers a preview of the noradrenergic modulation of long-term fear memory at the time of encoding.
Visser RM; Kunze AE; Westhoff B; Scholte HS; Kindt M
Psychoneuroendocrinology; 2015 May; 55():8-20. PubMed ID: 25705798
[TBL] [Abstract][Full Text] [Related]
27. Yohimbine depresses excitatory transmission in BNST and impairs extinction of cocaine place preference through orexin-dependent, norepinephrine-independent processes.
Conrad KL; Davis AR; Silberman Y; Sheffler DJ; Shields AD; Saleh SA; Sen N; Matthies HJ; Javitch JA; Lindsley CW; Winder DG
Neuropsychopharmacology; 2012 Sep; 37(10):2253-66. PubMed ID: 22617356
[TBL] [Abstract][Full Text] [Related]
28. Effects of noradrenergic and serotonergic systems on risk-based decision-making and center arena activity in open field in rats.
Cui R; Wang L; Liu L; Ruan H; Li X
Eur J Pharmacol; 2018 Dec; 841():57-66. PubMed ID: 30268663
[TBL] [Abstract][Full Text] [Related]
29. Serotonergic and noradrenergic dysregulation in alcoholism: m-chlorophenylpiperazine and yohimbine effects in recently detoxified alcoholics and healthy comparison subjects.
Krystal JH; Webb E; Cooney NL; Kranzler HR; Southwick SW; Heninger GR; Charney DS
Am J Psychiatry; 1996 Jan; 153(1):83-92. PubMed ID: 8540598
[TBL] [Abstract][Full Text] [Related]
30. Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.
McDougle CJ; Krystal JH; Price LH; Heninger GR; Charney DS
Psychopharmacology (Berl); 1995 Mar; 118(2):127-35. PubMed ID: 7617798
[TBL] [Abstract][Full Text] [Related]
31. Dopamine and Stress System Modulation of Sex Differences in Decision Making.
Georgiou P; Zanos P; Bhat S; Tracy JK; Merchenthaler IJ; McCarthy MM; Gould TD
Neuropsychopharmacology; 2018 Jan; 43(2):313-324. PubMed ID: 28741626
[TBL] [Abstract][Full Text] [Related]
32. A neurobiological correlate of stress-induced nicotine-seeking behavior among cigarette smokers.
Woodcock EA; Stanley JA; Diwadkar VA; Khatib D; Greenwald MK
Addict Biol; 2020 Jul; 25(4):e12819. PubMed ID: 31418989
[TBL] [Abstract][Full Text] [Related]
33. Effects of glucocorticoid and noradrenergic activity on implicit and explicit facial emotion recognition in healthy young men.
Chae WR; Metz S; Pantazidis P; Dziobek I; Hellmann-Regen J; Wingenfeld K; Otte C
Stress; 2021 Nov; 24(6):1050-1056. PubMed ID: 33860721
[TBL] [Abstract][Full Text] [Related]
34. Exogenous cortisol acutely influences motivated decision making in healthy young men.
Putman P; Antypa N; Crysovergi P; van der Does WA
Psychopharmacology (Berl); 2010 Feb; 208(2):257-63. PubMed ID: 19953227
[TBL] [Abstract][Full Text] [Related]
35. Effects of noradrenergic stimulation on memory in patients with major depressive disorder.
Wingenfeld K; Kuffel A; Uhlmann C; Terfehr K; Schreiner J; Kuehl LK; Otte C; Löwe B; Spitzer C
Stress; 2013 Mar; 16(2):191-201. PubMed ID: 22746337
[TBL] [Abstract][Full Text] [Related]
36. The effects of low doses of delta-9 tetrahydrocannabinol on reinforcement processing in the risky decision-making of young healthy adults.
Rogers RD; Wakeley J; Robson PJ; Bhagwagar Z; Makela P
Neuropsychopharmacology; 2007 Feb; 32(2):417-28. PubMed ID: 17006433
[TBL] [Abstract][Full Text] [Related]
37. Dopamine antagonism decreases willingness to expend physical, but not cognitive, effort: a comparison of two rodent cost/benefit decision-making tasks.
Hosking JG; Floresco SB; Winstanley CA
Neuropsychopharmacology; 2015 Mar; 40(4):1005-15. PubMed ID: 25328051
[TBL] [Abstract][Full Text] [Related]
38. No changes in triple network engagement following (combined) noradrenergic and glucocorticoid stimulation in healthy men.
Lipka R; Rosada C; Metz S; Hellmann-Regen J; Heekeren H; Wingenfeld K
Soc Cogn Affect Neurosci; 2024 Jan; 19(1):. PubMed ID: 38123464
[TBL] [Abstract][Full Text] [Related]
39. Enhanced Risky Choice in Male Rats Elicited by the Acute Pharmacological Stressor Yohimbine Involves Prefrontal Dopamine D1 Receptor Activation.
Münster A; Huster J; Sommer S; Traxler C; Votteler A; Hauber W
Int J Neuropsychopharmacol; 2024 Feb; 27(2):. PubMed ID: 38214654
[TBL] [Abstract][Full Text] [Related]
40. Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear.
Sperl MFJ; Panitz C; Skoluda N; Nater UM; Pizzagalli DA; Hermann C; Mueller EM
Int J Neuropsychopharmacol; 2022 Sep; 25(9):759-773. PubMed ID: 35748393
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
